According to Demis Hassabis on Twitter, DeepMind has launched AlphaGenome, a new AI-powered DNA sequence model now accessible through the AlphaGenome API. This model enables researchers to predict genome function with high accuracy, accelerating biological discovery and facilitating the development of innovative treatments. The integration of AlphaGenome into scientific workflows is expected to enhance genomics-driven drug discovery, streamline disease research, and create new business opportunities in AI-powered healthcare and precision medicine (source: @demishassabis, June 25, 2025).